Eupatilin (5,7-dihydroxy-3,4,6-trimethoxyflavone) is one of the main compounds present in Artemisia species. Eupatilin has both antioxidative and anti-inflammatory properties and a relaxation effect on vascular contraction regardless of endothelial function. We evaluated the relaxant effects of eupatilin on the corpus cavernosum (CC) of rabbits and the underlying mechanisms of its activity in human corpus cavernosum smooth muscle (CCSM) cells. Isolated rabbit CC strips were mounted in an organ bath system. A conventional whole-cell patch clamp technique was used to measure activation of calcium-sensitive K + -channel currents in human CCSM cells. The relaxation effect of eupatilin was evaluated by cumulative addition (10 À5 M~3 9 10 À4 M) to CC strips precontracted with 10 À5 M phenylephrine. Western blotting analysis was performed to measure myosin phosphatase targeting subunit 1 (MYPT1) and protein kinase C-potentiated inhibitory protein for heterotrimeric myosin light chain phosphatase of 17-kDa (CPI-17) expression and to evaluate the effect of eupatilin on the RhoA/Rho-kinase pathway. Eupatilin effectively relaxed the phenylephrine-induced tone in the rabbit CC strips in a concentration-dependent manner with an estimated EC 50 value of 1.2 AE 1.6 9 10 À4 M (n = 8, p < 0.05). Iberiotoxin and tetraethylammonium significantly reduced the relaxation effect (n = 8, p < 0.001 and p = 0.003, respectively). Removal of the endothelium or the presence of L-NAME or indomethacin did not affect the relaxation effect of eupatilin. In CCSM cells, the extracellular application of eupatilin 10 À4 M significantly increased the outward currents, and the eupatilin-stimulated currents were significantly attenuated by treatment with 10 À7 M iberiotoxin (n = 13, p < 0.05). Eupatilin reduced the phosphorylation level of MYPT1 at Thr853 of MLCP and CPI-17 at Thr38. Eupatilin-induced relaxation of the CCSM cells via NO-independent pathways. The relaxation effects of eupatilin on CCSM cells were partially due to activation of BK Ca channels and inhibition of RhoA/Rho-kinase.
INTRODUCTION
Artemisia asiatica Nakai is a traditional herbal medicine that is used as a hepatoprotective, antioxidative, anti-inflammatory, and antibacterial agent (Kalemba et al., 2002; Song et al., 2008; Choi et al., 2009; Ryoo et al., 2014) . Eupatilin (5,7-dihydroxy-3,4,6-trimethoxyflavone, PubChem CID: 5273755 ) is one of the major compounds present in Artemisia species and has been reported to possess a variety of biological activities. Eupatilin protects smooth muscle cells from indomethacin-induced cell damage and gastric epithelial cells from oxidative damage (Choi et al., 2008; Lee et al., 2008; Song et al., 2008) . Eupatilin inhibits the lipopolysaccharide-induced expression of inflammatory mediators in macrophages (Choi et al., 2011) . Eupatilin has a relaxation effect on vascular contraction regardless of endothelial function. Rho-kinase inhibition plays a major role in the mechanism responsible for eupatilin-induced vasorelaxation (Je et al., 2013) .
Smooth muscle contraction can occur even in the absence of changes to Ca 2+ ions via a calcium sensitization process that involves the RhoA/ Rho-kinase (ROK) mechanism through a complex molecular pathway (Sward et al., 2003) . Activated ROK increases the phosphorylation of smooth muscle myosin either directly by phosphorylating the myosin or indirectly by inhibiting the phosphatase responsible for dephosphorylating smooth muscle myosin . Both rabbit and human corpus cavernosum smooth muscle (CCSM) expresses both Rho-kinase isoforms (Wang et al., 2002; Chang et al., 2005) . Intracavernosal injection of the ROK selective inhibitor Y-27632 in normal rats results in penile erection (Chitaley et al., 2001) . Thus, ROK may play a major role in maintaining the CCSM in a flaccid state. Inhibition of the ROK pathway may serve as an effective treatment for erectile dysfunction (ED). The large-conductance Ca 2+ -activated K + (BK Ca ) channel has also been reported to play an important role in erectile function (Sung et al., 2015) . Werner et al., (2005) reported that loss of the BK Ca channel led to ED. A study using human penile tissue showed that activation of the BK Ca channel improved the vasodilatory capacity of PDE5 and enhanced erectile responses in rats (Gonzalez-Corrochano et al., 2013) . No reports have investigated the effect of eupatilin on the BK Ca channel.
Normal erectile function involves a coordinated relaxation of the arteries that supply the penis and the CCSM, resulting in expansion of the sinusoids and increased intracavernous pressure. The decrease in penile vascular resistance induced by CCSM relaxation is the most important step in penile erection. Although oral phosphodiesterase type 5 (PDE5) inhibitors have become a standard treatment, there is potential for treatment improvements through other pathways. New methods for the prevention of ED in high-risk groups and medications that can be taken in combination with PDE5 inhibitors to enhance penile erection are needed. Eupatilin has the potential to be an additional treatment agent for ED. We evaluated the relaxant effects of eupatilin on the rabbit corpus cavernosum (CC) and the mechanistic actions of eupatilin in human CCSM cells.
MATERIALS AND METHODS

Corpus cavernosum strip preparation
All animal experiments were conducted with the approval of the Institute for Animal Care and Use Committee of Samsung Medical Center (Seoul, South Korea, approval number: 20131220004) . Sexually mature male New Zealand white rabbits (n = 10, 2.5 AE 0.2 kg) were killed with an air embolism into the ear vein. Subsequently, the entire penis was surgically excised and cleaned by removing the corpus spongiosum and urethra. The corporal tissue was carefully dissected from the surrounding tunica. Three to four CC strips of approximately equal size (2 9 2 9 10 mm) were obtained from each penis and prepared separately for the organ bath studies. Each CC strip was tied with one end fixed to a tissue holder and the other end secured to a force transducer. The latter was connected to an appropriately calibrated four-channel polygraph (Power Lab; AD Instruments, Sydney, NSW, Australia) in which the transducer output was recorded. Throughout the study, the CC strips were maintained in organ baths in Krebs solution. The bath temperature was maintained at 37°C using a thermo-regulated water circuit and continuous bubbling with a mixture of 95% O 2 and 5% CO 2 .
Organ bath studies
The CC strip was equilibrated for 60 min with several length adjustments until the baseline force was stabilized at 1 g. After stabilization, phenylephrine (PE, 10 À5 M) was added. After a stable contraction plateau was reached, the relaxation effect of eupatilin was studied by cumulative addition at concentrations of 10 À5 M, 3 9 10 À5 M, 10 À4 M, and 3 9 10 À4 M. These eupatilin concentrations were selected based on pilot experiments. The role of the endothelium in eupatilin-induced relaxation was examined by comparing the magnitude of relaxation between the endothelium-intact and endothelium-denuded specimens. The endothelial lining of the CC was removed by rubbing the CC strip between the thumb and index finger for 20 sec and then soaking it in 0.3% CHAPS solution for 10 sec. Successful removal of the endothelium was confirmed in all tissues by the absence of response to the addition of acetylcholine (10 À6 M) to the CC strips. The concentration of eupatilin that inhibited 50% of the maximal contraction (EC 50 ) was calculated from the fit of the concentration-response curve data to a sigmoidal concentration-response function using GRAPHPAD PRISM (La Jolla, CA, USA).
To investigate the eupatilin-mediated relaxation pathway, we examined the effect of eupatilin on the PE-induced tone after pre-incubation of the CC strips with the non-specific potassium channel inhibitor tetraethylammonium (TEA, 10 À3 M), the nitric oxide synthase (NOS) blocker N-nitro-L-arginine methyl ester (L-NAME, 10 À4 M), the cyclooxygenase inhibitor indomethacin (10 À5 M), iberiotoxin (IbTX, 10 À7 M), which selectively inhibits the current through BK Ca channels, and the ATP-sensitive potassium channel inhibitor glibenclamide (10 À5 M) for 30 min. We compared the magnitude of relaxation before and after incubation.
Human corpus cavernosum smooth muscle cell cultures Human tissue was obtained from the CCs of patients with organic ED who were undergoing implantation of penile prostheses as previously described (Lee et al., 2013) . This study was approved by the Institutional Review Board of Samsung Medical Center (Seoul, South Korea, approval number: 2012-03-053) . The cells were maintained in Dulbecco's modified Eagle's medium (Gibco Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum and antibiotics (100 units/mL of penicillin and streptomycin; Gibco) under 5% CO 2 and were passaged every 3-4 days by detaching the cells from the culture dishes with 0.025% trypsin/EDTA (Gibco). Primary human CCSM cells were used between passages 2 and 4.
Electrophysiological studies
A whole-cell patch clamp technique was used to measure the Ca 2+ -activated potassium currents (BK Ca ) in human CCSM cells, as previously described (Kiesecker et al., 2006) . The cells were transferred to a small chamber (0.6 mL) on the stage of an inverted microscope (TMD Diaphot; Nikon, Tokyo, Japan), and the membrane currents were recorded using a patch clamp amplifier (Axopatch-200B; Axon Instruments, Foster City, CA, USA). Patch electrodes were made from borosilicate glass capillary tubing (World Precision Instruments, Sarasota, FL, USA) with 2.5-4 MΩ resistance. The liquid junctional potential between the pipette solution and the bath solution was onlỹ 3 mV, uncorrected. In each experiment, the whole-cell configuration was not achieved until the seal resistance became larger than 5 GΩ. The Digidata-1322A (Axon Instruments) and PCLAMP software v.9 (Axon Instruments) were used for data acquisition and the application of command pulses. Membrane currents were measured during ramping and filtered at 5 kHz (À3 dB frequency). The current signals were filtered at 5 kHz, digitized, and analyzed on a personal computer using the pCLAMP and ORIGIN software (Microcal Software, Northampton, MA, USA). The standard bath solution contained 135 9 10 À3 M NaCl, 5 9 10 À3 M KCl, 10 À3 M HEPES, 1.8 9 10 À3 M CaCl 2 , 10 À3 M MgCl 2 , and 5 9 10 À3 M glucose at a NaOH-adjusted pH of 7.4.
The pipette (internal) solution contained 140 9 10 À3 M KCl, 
Western blotting analysis
We measured the myosin phosphatase targeting subunit 1 (MYPT1) and the protein kinase C-potentiated inhibitory protein for heterotrimeric myosin light chain phosphatase of 17-kDa (CPI-17) expression levels in rabbit CC strips that were precontracted with 10 À5 M PE with and without exposure to eupatilin 3 9 10 À4 M for 30 min (Grassie et al., 2011; Je et al., 2013) . The isolated CC strips from the organ bath experiments were rapidly frozen by submerging them in liquid nitrogen and then stored at À80°C prior to the Western blotting analysis. The frozen tissue samples were homogenized in RIPA buffer (50 9 10 À3 M Tris-Cl, 150 9 10 À3 M NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, and 10 À3 M EDTA) containing a protease and phosphatase inhibitor cocktail (Calbiochem, La Jolla, CA, USA) and centrifuged at 13,000 g for 15 min at 4°C. The protein concentration was determined using the Bradford assay (Bio-Rad, Hercules, CA, USA 
Data interpretation and statistical analyzes
All data are expressed as the mean AE SEM, and the value of n refers to the number of separate CC strips or human CCSM cells. For the control, contractions induced by PE alone were recorded over time. The relaxant responses of isolated CC strip preparations are expressed as the percentage of relaxation compared with the control contractions. Non-specific relaxation of the CC strips was subtracted from the data readings. The statistical analyzes included paired and independent t-tests and one-way ANOVA. The Shapiro-Wilk test was used to determine the normality of the data. p-values <0.05 were considered significant.
RESULTS
Effects of eupatilin on rabbit corpus cavernosum strips
Eupatilin effectively decreased the phenylephrine-induced tone in the rabbit CCs in a concentration-dependent manner, with an estimated EC 50 value of 1.2 AE 1.6 9 10 À4 M; 2.9 AE 5.3%
at 10 À5 M, 14.5 AE 8.8% at 3 9 10 À5 M, 55.0 AE 7.2% at 10 À4 M, and 99.1 AE 5.2% at 3 9 10 À4 M (n = 8, p < 0.05). Removal of the endothelium from the CC strips did not influence the relaxation effect of eupatilin at any concentration, with an estimated EC 50 value of 1.6 AE 2.1 9 10 À4 M; 4.6 AE 2.5% at 10 À5 M, 21.6 AE 2.1% at 3 9 10 À5 M, at 57.3 AE 11.7% 10 À4 M, and 98.3 AE 7.0% at 3 9 10 À4 M (Fig. 1) . Iberiotoxin and tetraethylammonium significantly reduced the relaxation effect of 10 À4 M eupatilin (n = 8, p < 0.001 and p = 0.003, respectively). The presence of L-NAME, indomethacin and glibenclamide did not influence the relaxation effect of 10 À4 M eupatilin (Fig. 2) .
Effects of eupatilin on BK Ca currents in human corpus cavernosum smooth muscle cells
At a À60 mV holding potential with an external solution containing 5 9 10 À3 M K + , the extracellular application of 10 À5 M and 10 À4 M eupatilin significantly increased the outward currents. This effect was significantly attenuated by treatment with 10 À7 M iberiotoxin (IbTX), which is a selective blocker of BK Ca channels (n = 13, p < 0.05, Fig. 3A,B) . Eupatilin increased the current density from 9.9 AE 1.2 pA/pF to 20.4 AE 4.4 pA/pF with 10 À5 M eupatilin and to 24.4 AE 5.7 pA/pF with 10 À4 M eupatilin at +60 mV (p < 0.05, n = 13, Fig. 3C ).
Effects of eupatilin on the CPI-17 phosphorylation level at Thr38 and the MYPT1 phosphorylation level at Thr853
To confirm the role of the ROK pathway in eupatilin-induced smooth muscle relaxation, we conducted a Western blotting analysis to measure the CPI-17 phosphorylation level at Thr38 and the MYPT1 phosphorylation level at Thr853. The phospho-MYPT1 protein level was significantly decreased in the quickfrozen eupatilin-treated rabbit CC strips compared with the vehicle-treated rabbit CC strips (1.61 vs. 4.69, p < 0.05, n = 4, Fig. 4A ). The phospho-CPI-17 protein level was also significantly decreased in the quick-frozen eupatilin-treated rabbit CC strips compared with the vehicle-treated rabbit CC strips (0.77 vs. 3.14, p < 0.05, n = 4, Fig. 4B ).
DISCUSSION
ED is a common disorder with many causes, including endothelial impairment, a low testosterone level, prior surgical manipulation, and/or psychogenic components. The interaction between nitric oxide (NO) and paraventricular oxytocinergic neurons is a crucial mechanism of erection central regulation (Zhang et al., 2011) . NO-induced cGMP-mediated vasorelaxation is the main target pathway of current ED treatments. However, PDE5 inhibitor therapies do not help all men with ED. Certain etiologies, including diabetes, are difficult to treat with Figure 2 The relaxation effect of eupatilin (55.0 AE 7.2% at 10 À4 M) was blocked by pretreatment with 10 À3 M TEA (36.6 AE 12.6%, n = 8, p = 0.003) and 10 À7 M IbTX (21.5 AE 9.2%, n = 8, p < 0.001). Pre-treatment with 10 À4 M L-NAME (45.6 AE 11.4%, n = 8, p = 0.068), 10 À5 M indomethacin (56.8 AE 7.6%, n = 7, p = 0.825) and 10 À6 M glibenclamide (48.3 AE 14.6%, n = 8, p = 0.266) did not affect the eupatilin-induced relaxation. Eup, eupatilin 10 À4 M; TEA, tetraethylammonium; IbTX, iberiotoxin; L-NAME, N-nitro-L-arginine methyl ester; *p < 0.05. Figure 3 Activation of whole-cell BK Ca currents in human corporal smooth muscle cells by eupatilin: (A) Typical current-voltage relationships obtained using a 500-ms ramp pulse from À80 to +80 mV; membrane currents were recorded in the absence (control) and presence of eupatilin. (B) Eupatilin-activated current was blocked by iberiotoxin. (C) Summary of the peak current densities at +60 mV (normalized to cell capacitance); n = 13; *, p < 0.05. Eup, eupatilin; IbTX, iberiotoxin.
the current modalities. Many novel approaches are under investigation, including the use of melanocortins and Rho-kinase inhibitors, gene therapy and tissue engineering (Williams & Melman, 2012) . Alcohol-based plant infusions are popular in both Europe and Asia. Artemisia species have long been used to flavor alcoholic beverages, giving them a bitter taste and alleged tonic properties (Vouillamoz et al., 2015) . Artemisia asiatica Nakai is used as an herbal medicine with hepatoprotective, antioxidative, antiinflammatory, and antibacterial effects (Je et al., 2013) . Eupatilin is an ethanol extract of Artemisia asiatica Nakai and is available as a commercial drug (Stillen Ⓡ ; Dong-A Pharmaceutical Co., Ltd, South Korea) that is widely used to treat gastritis and peptic ulcers. A recent study showed that eupatilin-modulated vascular contractility and that Rho-kinase inhibition was a major component of the mechanism responsible for the eupatilin-induced vasorelaxation (Je et al., 2013) . To the best of our knowledge, this study is the first to investigate eupatilin as a potential ED treatment. The major findings of this study were that eupatilin inhibited the contraction of rabbit CC strips in a dose-dependent manner and that the NO pathway seemed not to be involved in the relaxation response. Neither the removal of the endothelium nor the addition of the NO synthesis inhibitor L-NAME affected the relaxation response with eupatilin, thereby excluding a role for the NO pathways. The inhibitory effects of TEA suggested a potential role of K + channels, and the results of glibenclamide experiments excluded a possible role of the ATP-sensitive potassium channel. IbTX significantly interfered with the eupatilin-induced CC relaxation, which suggested a role of BK Ca channels; this finding was confirmed by a whole-cell patch clamp study using human CCSM cells. In the CCSM, K + channels are important in determining the smooth muscle tone and serve as targets for neurotransmitters and other messengers that act on smooth muscle (Han et al., 2012) . ROK signaling, which acts by potentiating Ca
2+
-dependent contraction to maintain penile flaccidity, is important for erectile homeostasis (Sopko et al., 2014) . Dysregulation of the ROK pathway plays an important role in the etiology of erectile dysfunction. Activation of the Rho-kinase inactivates the myosin light chain phosphatase (MLCP) by phosphorylation of MYPT1 and CPI-17 (Yang et al., 2010; Grassie et al., 2011) . The principal mechanism of MYPT1 regulatory functions involves phosphorylation within the central region by a variety of protein serine/ threonine kinases. The best understood regulatory mechanism is the phosphorylation of MYPT1 at T696 and T853, which is catalyzed by the ROK pathways Grassie et al., 2011) . Rho kinase directly phosphorylates MYPT1 at Thr696/ Thr853 and consequently inhibits phosphatase activity (Pang et al., 2005) . MYPT1 phosphorylation at Thr853 has been shown to induce dissociation of MYPT1 from myosin. CPI-17 was first identified as a substrate of protein kinase C at Thr38, whereas Rho-kinase phosphorylated Thr38 and activated CPI-17 (Koyama et al., 2000; Yang et al., 2010) . Accordingly, we used the ratio of phosphorylated MYPT1 to total MYPT1 and phosphorylated CPI-17 to total CPI-17 as indices of Rho-kinase activity (Koyama et al., 2000; Velasco et al., 2002; Grassie et al., 2011) . The phosphorylated MYPT1 and phosphorylated CPI-17 protein levels were significantly decreased by eupatilin in the CC strips. This result suggests that the ROK pathway plays an important role in the relaxation effect of eupatilin.
ROK pathways are present in many tissues throughout the body and regulate various functions (Breitenlechner et al., 2003; Priviero et al., 2010) . The role of the ROK pathway in penile Figure 4 Effect of eupatilin on the phosphorylation levels of MYPT1 and CPI-17 (A) Representative Western blots of the phosphorylated and total MYPT1 bands. pMYPT1 was significantly decreased in the eupatilin-treated strips. erection is to modulate the contractile state of the cavernous sinusoidal and arteriolar smooth muscle cells. The RhoA and Rho-kinase concentrations are 17-fold greater in the smooth muscle of the rabbit CC than in the ileum (Sopko et al., 2014) . Several studies using a ROK inhibitor (Y-27632) showed that inhibition of ROK caused direct smooth muscle relaxation in the penis, thereby enhancing penile erection (Chitaley et al., 2001; Wang et al., 2002) . Inhibition of the ROK pathway induces improved erectile hemodynamics independent of NO synthesis in the penis and may be an alternative to PDE5 inhibitors for the treatment of ED in some refractory patients, including those with diabetes or post-prostatectomy ED. Some ROK inhibitors, including azaindole-1 and SAR407899, are under investigation as potential ED drugs. Although the process is far from clinical application, eupatilin shows signs of having potential as a new therapeutic agent for refractory ED through ROK inhibitory mechanisms. Although our study is the first step in investigations of eupatilin as a potential ED drug, our data are limited to in vitro studies. Thus, in vivo animal studies are needed. Disappointingly, no human data on the oral absorption of eupatilin are available, although eupatilin is a commercially available drug. In one animal study, eupatilin was found to not be easily absorbed (Jang et al., 2003) . Further investigations to identify and specify the relaxation mechanisms underlying eupatilin for the development of effective drug-delivery methods are necessary.
CONCLUSIONS
In conclusion, we found that eupatilin relaxes the CC via NO-independent pathways, including activation of the BK Ca channels and inhibition of the ROK pathways. Although this study is only a pilot study, and more investigations including in vivo experiments are necessary, our findings suggest that eupatilin may be a therapeutic candidate for ED patients.
